Grigsby P, Elhammali A, Ruiz F, Markovina S, McLellan MD, Miller CA, Chundury A, Ta NL, Rashmi R, Pfeifer JD, Fulton RS, DeWees T, Schwarz JK. Clinical outcomes and differential effects of PI3K pathway mutation in obese versus non-obese patients with cervical cancer. Oncotarget. 2017 Dec 23;9(3):4061-4073. doi: 10.18632/oncotarget.23664. eCollection 2018 Jan 9. PMID: 29423104

Markovina S, Wang S, Henke LE, Luke CJ, Pak SC, DeWees T, Pfeifer JD, Schwarz JK, Liu W, Chen S, Mutch D, Wang X, Powell MA, Siegel BA, Dehdashti F, Silverman GA, Grigsby PW. Serum squamous cell carcinoma antigen as an early indicator of response during therapy of cervical cancer. Br J Cancer. 2018 Jan;118(1):72-78. doi: 10.1038/bjc.2017.390. Epub 2017 Nov 7. PMID: 29112685

Cancer Genome Atlas Research Network (inc. Grigsby PW and Schwarz JK). Integrated genomic and molecular characterization of cervical cancer. Nature. 2017 Mar 16;543(7645):378-384. doi: 10.1038/nature21386. Epub 2017 Jan 23. PMID: 28112728

Dyk P, Jiang N, Sun B, DeWees TA, Fowler KJ, Narra V, Garcia-Ramirez JL, Schwarz JK, Grigsby PW. Cervical gross tumor volume dose predicts local control using magnetic resonance imaging/diffusion-weighted imaging-guided high-dose-rate and positron emission tomography/computed tomography-guided intensity modulated radiation therapy. Int J Radiat Oncol Biol Phys. 2014 Nov 15;90(4):794-801. doi: 10.1016/j.ijrobp.2014.07.039. Epub 2014 Sep 20. PMID: 25245584

Kidd EA, Siegel BA, Dehdashti F, Rader JS, Mutch DG, Powell MA, Grigsby PW. Lymph node staging by positron emission tomography in cervical cancer: relationship to prognosis. J Clin Oncol. 2010 Apr 20;28(12):2108-13. doi: 10.1200/JCO.2009.25.4151. Epub 2010 Mar 22. PMID: 20308664

Schwarz JK, Siegel BA, Dehdashti F, Grigsby PW. Association of posttherapy positron emission tomography with tumor response and survival in cervical carcinoma. JAMA. 2007 Nov 21;298(19):2289-95. PMID: 18029833